{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:20:14Z","timestamp":1776259214410,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-19017-7","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:26:26Z","timestamp":1769538386000},"page":"3899-3909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Background Liver Fibrosis as a Microenvironmental Risk Factor for Intrahepatic Recurrence in Colorectal Liver Metastases"],"prefix":"10.1245","volume":"33","author":[{"given":"Satoru","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kurebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokiya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Seishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"19017_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin."},{"key":"19017_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jso.27320","volume":"127","author":"BJ Kim","year":"2023","unstructured":"Kim BJ, Hanna MH. Colorectal cancer in young adults. J Surg Oncol. 2023;127:1247\u201351. https:\/\/doi.org\/10.1002\/jso.27320.","journal-title":"J Surg Oncol."},{"key":"19017_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA."},{"key":"19017_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/hep.13.3","volume":"1","author":"DF Dunne","year":"2014","unstructured":"Dunne DF, Jones RP, Malik HZ, Fenwick SW, Poston GJ. Surgical management of colorectal liver metastases: a European perspective. Hepat Oncol. 2014;1:121\u201333. https:\/\/doi.org\/10.2217\/hep.13.3.","journal-title":"Hepat Oncol."},{"key":"19017_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s11864-022-01008-5","volume":"23","author":"MC Riesco-Martinez","year":"2022","unstructured":"Riesco-Martinez MC, Modrego A, Espinosa-Olarte P, La Salvia A, Garcia-Carbonero R. Perioperative chemotherapy for liver metastasis of colorectal cancer: lessons learned and future perspectives. Curr Treat Options in Oncol. 2022;23:1320\u201337. https:\/\/doi.org\/10.1007\/s11864-022-01008-5.","journal-title":"Curr Treat Options in Oncol."},{"key":"19017_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/annonc\/mdw206","volume":"27","author":"K Yamazaki","year":"2016","unstructured":"Yamazaki K, Nagase M, Tamagawa H, et al. Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G). Ann Oncol. 2016;27:1539\u201346. https:\/\/doi.org\/10.1093\/annonc\/mdw206.","journal-title":"Ann Oncol."},{"key":"19017_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851\u201361. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"19017_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44276-024-00050-0","volume":"2","author":"PJ Johnson","year":"2024","unstructured":"Johnson PJ, Kalyuzhnyy A, Boswell E, Toyoda H. Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management. BJC Rep. 2024;2:1\u20137. https:\/\/doi.org\/10.1038\/s44276-024-00050-0.","journal-title":"BJC Rep."},{"key":"19017_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/bjc.2016.155","volume":"115","author":"T Kondo","year":"2016","unstructured":"Kondo T, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kitagawa Y. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer. Br J Cancer. 2016;115:34\u20139. https:\/\/doi.org\/10.1038\/bjc.2016.155.","journal-title":"Br J Cancer."},{"key":"19017_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.62347\/JHMS4303","volume":"14","author":"S Dai","year":"2024","unstructured":"Dai S, Liu C, Chen L, et al. Hepatic steatosis predicts metachronous liver metastasis in colorectal cancer patients: a nested case\u2013control study and systematic review. Am J Cancer Res. 2024;14:1292\u2013305. https:\/\/doi.org\/10.62347\/JHMS4303.","journal-title":"Am J Cancer Res."},{"key":"19017_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, et al. Albumin\u2013bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. BJS. 2016;103:725\u201334. https:\/\/doi.org\/10.1002\/bjs.10095.","journal-title":"BJS."},{"key":"19017_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection: comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u20136. https:\/\/doi.org\/10.1002\/hep.21669.","journal-title":"Hepatology."},{"key":"19017_CR13","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/jcm13113132","volume":"13","author":"H Bader","year":"2024","unstructured":"Bader H, Yamin S, Alshahwan H, Farraj H, Maghnam J, Abu Omar YA. Association between metabolic-dysfunction-associated steatotic liver disease and hepatic cancer: current concepts and future challenges. JCM. 2024;13:3132. https:\/\/doi.org\/10.3390\/jcm13113132.","journal-title":"JCM."},{"key":"19017_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/pin.12064","volume":"63","author":"T Abe","year":"2013","unstructured":"Abe T, Hashiguchi A, Yamazaki K, et al. Quantification of collagen and elastic fibers using whole-slide images of liver biopsy specimens. Pathol Int. 2013;63:305\u201310. https:\/\/doi.org\/10.1111\/pin.12064.","journal-title":"Pathol Int."},{"key":"19017_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/2153-3539.124009","volume":"4","author":"Y Murakami","year":"2013","unstructured":"Murakami Y, Abe T, Hashiguchi A, Yamaguchi M, Saito A, Sakamoto M. Color correction for automatic fibrosis quantification in liver biopsy specimens. J Pathol Inform. 2013;4:36. https:\/\/doi.org\/10.4103\/2153-3539.124009.","journal-title":"J Pathol Inform."},{"key":"19017_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/hep4.1121","volume":"2","author":"Y Masugi","year":"2018","unstructured":"Masugi Y, Abe T, Tsujikawa H, et al. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Comm. 2018;2:58\u201368. https:\/\/doi.org\/10.1002\/hep4.1121.","journal-title":"Hepatol Comm."},{"key":"19017_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00534-011-0460-z","volume":"19","author":"T Beppu","year":"2012","unstructured":"Beppu T, Sakamoto Y, Hasegawa K, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepato-Biliary-Pancreat Sci. 2012;19:72\u201384. https:\/\/doi.org\/10.1007\/s00534-011-0460-z.","journal-title":"J Hepato-Biliary-Pancreat Sci."},{"key":"19017_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309.","journal-title":"Ann Surg."},{"key":"19017_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jhbp.1256","volume":"30","author":"T Beppu","year":"2023","unstructured":"Beppu T, Yamamura K, Sakamoto K, et al. Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era: a nationwide survey in Japan. J Hepato-Biliary-Pancreatic Sci. 2023;30:591\u2013601. https:\/\/doi.org\/10.1002\/jhbp.1256.","journal-title":"J Hepato-Biliary-Pancreatic Sci."},{"key":"19017_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/XCS.0000000000000557","volume":"236","author":"Z Moazzam","year":"2023","unstructured":"Moazzam Z, Alaimo L, Endo Y, et al. Combined tumor burden score and carbohydrate antigen 19\u20139 grading system to predict outcomes among patients with intrahepatic cholangiocarcinoma. J Am Coll Surg. 2023;236:804\u201313. https:\/\/doi.org\/10.1097\/XCS.0000000000000557.","journal-title":"J Am Coll Surg."},{"key":"19017_CR21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1245\/s10434-024-16633-7","volume":"32","author":"M Akabane","year":"2025","unstructured":"Akabane M, Kawashima J, Woldesenbet S, et al. ASO visual abstract: improving recurrence prediction in intrahepatic cholangiocarcinoma: the synergistic impact of FIB-4 index and tumor burden score in post-hepatectomy outcomes. Ann Surg Oncol. 2025;32:1112\u20133. https:\/\/doi.org\/10.1245\/s10434-024-16633-7.","journal-title":"Ann Surg Oncol."},{"key":"19017_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11605-019-04123-1","volume":"24","author":"P Zhou","year":"2020","unstructured":"Zhou P, Chen B, Miao XY, et al. Comparison of FIB-4 index and Child-Pugh score in predicting the outcome of hepatic resection for hepatocellular carcinoma. J Gastrointest Surg. 2020;24:823\u201331. https:\/\/doi.org\/10.1007\/s11605-019-04123-1.","journal-title":"J Gastrointest Surg."},{"key":"19017_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol A, Saito Y, Nair A, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022;610:356\u201365. https:\/\/doi.org\/10.1038\/s41586-022-05289-6.","journal-title":"Nature."},{"key":"19017_CR24","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009.","journal-title":"Cancer Cell."},{"key":"19017_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jhep.2014.02.003","volume":"60","author":"C Coulouarn","year":"2014","unstructured":"Coulouarn C, Cl\u00e9ment B. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma. J Hepatol. 2014;60:1306\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2014.02.003.","journal-title":"J Hepatol."},{"key":"19017_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jso.28007","author":"J Kawashima","year":"2024","unstructured":"Kawashima J, Akabane M, Endo Y, et al. Recurrence timing and risk following curative resection of colorectal liver metastases: insights from a hazard function analysis. J Surg Oncol. 2024. https:\/\/doi.org\/10.1002\/jso.28007.","journal-title":"J Surg Oncol."},{"key":"19017_CR27","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s11605-023-05672-2","volume":"27","author":"Y Endo","year":"2023","unstructured":"Endo Y, Alaimo L, Sasaki K, et al. Liver transplantation for colorectal liver metastases: hazard function analysis of data from the organ procurement and transplantation network. J Gastrointest Surg. 2023;27:1720\u20132. https:\/\/doi.org\/10.1007\/s11605-023-05672-2.","journal-title":"J Gastrointest Surg."},{"key":"19017_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1245\/s10434-019-07934-3","volume":"27","author":"RR Narayan","year":"2020","unstructured":"Narayan RR, Harris JW, Chou JF, et al. Prediction of recurrence patterns from hepatic parenchymal disease after resection of colorectal liver metastases. Ann Surg Oncol. 2020;27:188\u201395. https:\/\/doi.org\/10.1245\/s10434-019-07934-3.","journal-title":"Ann Surg Oncol."},{"key":"19017_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40169-020-0264-3","volume":"9","author":"X Hu","year":"2020","unstructured":"Hu X, Marietta A, Dai WX, et al. Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores. Clin Transl Med. 2020;9:13. https:\/\/doi.org\/10.1186\/s40169-020-0264-3.","journal-title":"Clin Transl Med."},{"key":"19017_CR30","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-020-08828-5","volume":"27","author":"T Akiyama","year":"2020","unstructured":"Akiyama T, Miyamoto Y, Imai K, et al. Fibrosis-4 index, a noninvasive fibrosis marker, predicts survival outcomes after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. 2020;27:3534\u201341. https:\/\/doi.org\/10.1245\/s10434-020-08828-5.","journal-title":"Ann Surg Oncol."},{"key":"19017_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gut.2005.084475","volume":"55","author":"RA Standish","year":"2006","unstructured":"Standish RA. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55:569\u201378. https:\/\/doi.org\/10.1136\/gut.2005.084475.","journal-title":"Gut."},{"key":"19017_CR32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/hep.24271","volume":"53","author":"EA Tsochatzis","year":"2011","unstructured":"Tsochatzis EA, Germani G, Hall A, Anousou PM, Dhillon AP, Burroughs AK. Noninvasive assessment of liver fibrosis: the need for better validation. Hepatology. 2011;53:1781. https:\/\/doi.org\/10.1002\/hep.24271.","journal-title":"Hepatology."},{"key":"19017_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.006.","journal-title":"J Hepatol."},{"issue":"6","key":"19017_CR34","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Grootes JD, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139.","journal-title":"J Hepatol"},{"key":"19017_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0168-8278(02)00357-4","volume":"38","author":"R Rozario","year":"2003","unstructured":"Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol. 2003;38:223\u20139. https:\/\/doi.org\/10.1016\/S0168-8278(02)00357-4.","journal-title":"J Hepatol."},{"key":"19017_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ajcp\/aqy134","volume":"151","author":"KM Waters","year":"2019","unstructured":"Waters KM, Cottrell TR, Besharati S, Zhu Q, Anders RA. Evaluation of peritumoral fibrosis in metastatic colorectal adenocarcinoma to the liver using digital image analysis. Am J Clin Pathol. 2019;151:226\u201330. https:\/\/doi.org\/10.1093\/ajcp\/aqy134.","journal-title":"Am J Clin Pathol."},{"key":"19017_CR37","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/MPA.0000000000001179","volume":"47","author":"Y Fujita","year":"2018","unstructured":"Fujita Y, Kitago M, Abe T, et al. Evaluation of pancreatic fibrosis with acoustic radiation force impulse imaging and automated quantification of pancreatic tissue components. Pancreas. 2018;47:1277\u201382. https:\/\/doi.org\/10.1097\/MPA.0000000000001179.","journal-title":"Pancreas."},{"key":"19017_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2023.10.015","volume":"80","author":"V Ratziu","year":"2024","unstructured":"Ratziu V, Hompesch M, Petitjean M, et al. Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions. J Hepatol. 2024;80:335\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.015.","journal-title":"J Hepatol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19017-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19017-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19017-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:26:25Z","timestamp":1776255985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19017-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19017"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19017-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For Yuko Kitagawa, relevant financial activities outside the submitted work involved, Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Kyouwa Kirin Co., Ltd., Kowa Company, Ltd., Asahi Kasei Pharma Corporation, AstraZeneca K.K., Ethicon Inc., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Olympus Corporation, Cardinal Health K.K., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., MSD K.K., Smith & Nephew K.K., Kaken Pharmaceutical Co., Ltd., ASKA Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co. Ltd., Toray Industries, Inc., Daiichi Sankyo Company, Limited, Chugai Foundation for Innovative Drug, Discovery Science, Nippon Kayaku Co., Ltd., EA Pharma Co., Ltd., Intuitive Surgical G.K., Takeda Pharmaceutical Company Limited, Sysmex Corporation, Tsumura & Co., AI Medical Service Inc., Kowa Company, Ltd., Eisai Co., Ltd., Joint Research Laboratory for Development and Education of Innovative Medical Technology, Sysmex Corporation, and Medicaroid Corporation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}